Kanion Pharmaceutical(SH:600557) Zheng Quan Zhi Xing·2025-04-02 13:20Core Viewpoint - The document outlines the insider information management system of Jiangsu Kangyuan Pharmaceutical Co., Ltd., emphasizing the importance of confidentiality and compliance with relevant laws and regulations [1][2]. Group 1: Insider Information Management - The company establishes a system to manage insider information, ensuring confidentiality and fair disclosure in accordance with Chinese laws and regulations [1][2]. - The board of directors is responsible for overseeing the management of insider information, with the chairman being the primary accountable person [1][2]. - The board secretary is tasked with implementing the insider information management system and ensuring accurate records of insider information personnel [2][3]. Group 2: Scope of Insider Information - Insider information refers to non-public information that could significantly impact the company's operations, finances, or stock market prices [1][5]. - Major events that could affect stock prices include significant changes in business strategy, major asset transactions exceeding 30% of total assets, and substantial losses or debts [3][4]. Group 3: Confidentiality Obligations - Individuals with access to insider information must not disclose it to external parties or use it for personal gain, including trading company securities [6][7]. - The company must ensure that all personnel involved in insider information management adhere to strict confidentiality protocols [6][7]. Group 4: Record Keeping and Reporting - The company is required to maintain detailed records of all individuals who have access to insider information prior to its public disclosure [15][19]. - Following the public disclosure of insider information, the company must submit relevant records to the stock exchange within five trading days [10][11]. Group 5: Penalties for Violations - Individuals who leak insider information or engage in insider trading may face disciplinary actions from the company's board of directors [22][23]. - The company retains the right to pursue legal action against those who improperly disclose information, resulting in financial losses [23][24].